Clinical Trials Sponsored by Beijing ShuangLu Pharmaceutical Co., Ltd.

Total 4336 results

Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Completed

Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

China
Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Completed

A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Unknown

A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
Beijing Tide Pharmaceutical Co., Ltd

Not yet recruiting

A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough

Refractory Chronic Cough
Beijing Tide Pharmaceutical Co., Ltd

Recruiting

A Phase I/II Clinical Study in Patients With Advanced Solid Tumor.

Patients With Advanced Solid Tumors

China
Beijing Continent Pharmaceutical Co, Ltd.

Recruiting

F573 for Injection for the Treatment of Liver Injury/Failure

Acute-On-Chronic Liver Failure | Acute Liver Failure

China
Beijing Continent Pharmaceutical Co, Ltd.

Recruiting

Hydronidone for the Treatment of Liver Fibrosis Associated With Chronic Viral Hepatitis B Phase 3 Trial.

Liver Fibrosis

China
Beijing Konruns Pharmaceutical Co., Ltd.

Completed

A Food Effect Study of KC1036 in Healthy Subjects

Healthy Subjects

China
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer

Esophageal Squamous Cell Carcinoma

China
Beijing Tide Pharmaceutical Co., Ltd

Not yet recruiting

TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD))

GVHD, Chronic
Beijing Tide Pharmaceutical Co., Ltd

Not yet recruiting

A Clinical Trial on the Treatment of Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

Chronic Pelvic Pain

China
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

To Evaluate KC1036 in the Patients With Advanced Digestive System Tumors

Digestive System Tumors

China
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

A Study of KC1036 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Beijing Continent Pharmaceutical Co, Ltd.

Completed

Study on PK of Hydronidone in Patients and Special Population

Hepatitis b & Liver Dysfunction

China
Beijing Continent Pharmaceutical Co, Ltd.

Completed

Study on Hydronidone Capsule BE

Healthy

China
Beijing Continent Pharmaceutical Co, Ltd.

Unknown

Efficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD)

Dermatomyositis Interstitial Lung Disease (Dm-ILD)

China
Beijing Continent Pharmaceutical Co, Ltd.

Recruiting

Hydroxynidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis

Liver Fibrosis

China
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

A Study of KC1036 in Patients With Advanced Thymic Tumors

Thymic Tumors

China
Beijing Continent Pharmaceutical Co, Ltd.

Not yet recruiting

Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis

Pneumoconiosis
Beijing Continent Pharmaceutical Co, Ltd.

Recruiting

Pirfenidone Capsule in Patients With Chronic Kidney Disease G2 and G3a Study on Safety and Pharmacokinetics

Renal Insufficiency

China
Beijing Continent Pharmaceutical Co, Ltd.

Completed

F573 Ia Clinical Trial

Tolerance | Pharmacokinetic

China
Beijing Konruns Pharmaceutical Co., Ltd.

Completed

The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

Chronic Pelvic Pain

China
Beijing Continent Pharmaceutical Co, Ltd.

Terminated

A Study About Safety and Efficacy of Pirfenidone to Treat Grade 2 or Grade3 Radiation-induced Lung Injury.

Radiation-induced Lung Injury

China
Beijing Continent Pharmaceutical Co, Ltd.

Completed

Study on Pharmacokinetics of Hydronidone

Pharmacokinetics of Hydronidone

China
Beijing Continent Pharmaceutical Co, Ltd.

Completed

Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects

Hydronidone

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Not yet recruiting

Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation

Atrial Fibrillation
Beijing Suncadia Pharmaceuticals Co., Ltd

Not yet recruiting

A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction

Brain Swelling, Large Hemispheric Infarction
Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Locally Advanced or Metastatic Non-Small Cell Lung Cancer

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Active, not recruiting

Safety and Tolerability of SHR-1918 in Healthy Subjects

Hyperlipemia

China
Beijing Biostar Pharmaceuticals Co., Ltd.

Completed

Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer

Breast Cancer

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Recruiting

Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic

Hyperlipidemic

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Recruiting

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Prevention of Venous Thromboembolism After Knee Arthroplasty

China
Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer

Breast Cancer

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery

Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
Beijing Suncadia Pharmaceuticals Co., Ltd

Not yet recruiting

Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Homozygous Familial Hypercholesterolemia
Beijing Suncadia Pharmaceuticals Co., Ltd

Not yet recruiting

Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects

Diabetes
Beijing Suncadia Pharmaceuticals Co., Ltd

Active, not recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy Subjects

Prevention of Arterial and Venous Thrombosis

China
Overseas Pharmaceuticals, Ltd.
Beijing Capton Pharmaceutical Technology Development Co., LTD

Not yet recruiting

An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic（PK）Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions.

Epilepsy

China
Henan Cancer Hospital
Qilu Pharmaceutical Co., Ltd.; Beijing Biostar Pharmaceuticals Co., Ltd.

Not yet recruiting

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

HER-2 Negative Breast Cancer
Beijing Kejing Biotechnology Co., Ltd.
Beijing Kejing Biotechnology Corp.

Withdrawn

An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients (CCT-ANK-11)

Solid Tumors (Pancreatic Cancer, Esophageal Cancer, Gastric Cancer, Cholangiocarcinoma, Lung Cancer and Ovarian Cancer)

China
Beijing Nuokangda Pharmaceutical Technology Co....

Unknown

Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor

Solid Tumor

China
Beijing Mabworks Biotech Co., Ltd.
Betta Pharmaceuticals Co., Ltd.

Completed

mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.

Completed

A Study to Investigate the Safety and Efficacy of Ricolinostat

Peripheral Nervous System Diseases

China
Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.

Completed

Evaluate the Safety and Pharmacokinetics of Ricolinostat

Peripheral Nervous System Diseases

China
Beijing Tongren Hospital
Beijing Winsunny Pharmceutical Co.,Ltd.

Completed

Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers

Obsessive-Compulsive Disorder | Generalized Anxiety Disorder | Major Depressive Disorder | Social Anxiety Disorder | Panic Disorder

China
Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.

Completed

Pre-study to Evaluate IENFD Induction in Patients With Taxane-induced CIPN

Peripheral Nervous System Diseases

China
Xijing Hospital of Digestive Diseases
Beijing Tide Pharmaceutical Co., Ltd

Completed

Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer

Esophageal Neoplasms

China
Peking University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Beijing Biostar Pharmaceuticals...

Recruiting

Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer

Esophageal Cancer

China

Clinical Trials Sponsored by Beijing ShuangLu Pharmaceutical Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations